Skip to main content

Strategies for the design of epitope targeting vaccines

Resource type
Thesis type
(Thesis) Ph.D.
Date created
2007
Authors/Contributors
Abstract
There is need for vaccines that target production of antibodies (Ab) to conserved sites on highly-variable pathogens, such as HIV-1. Strategies targeting Ab production to such sites are called “epitope-targeting vaccines”, and this dissertation explores this theme by: i) using filamentous phage-based carriers for focusing Ab responses to peptides, and ii) developing a protein-prime, peptide-boost immunization strategy for targeting Ab production to a specific epitope on a protein. In Chapter 2, phage are compared as a carrier for a synthetic peptide to the classical carrier protein, ovalbumin (OVA). Both immunogens elicited strong anti-peptide Ab titers, with those elicited by OVA-peptide conjugate exceeding those produced by phage-peptide conjugate. Comparison of the anti-peptide and anti-carrier Ab responses showed that phage-peptide conjugate elicited a more focused anti-peptide Ab response than OVA-peptide conjugate. In Chapter 3, the dominant epitopes on phage are removed or altered. Engineered phage are tested as immunogens to determine if reduction of B-cell epitopes on the virion could further focus an Ab response against a peptide. One engineered phage variant (Δ3) produced lower Ab titers than wild type (WT) phage. A recombinant peptide displayed on the surface of the Δ3 phage immunogen produced a poor anti-peptide Ab responses compared to WT. In contrast, the Δ3 phage did focus an Ab response against a chemically-conjugated synthetic peptide compared to WT. These differences may be due to variation in copy number or inherent peptide immunogenicity. Chapter 4 tests if an Ab-specific peptide can selectively amplify an oligoclonal population of memory B-cells that were primed by an immunization with the polyclonal antigen hen egg lysozyme (HEL). This approach is enhanced by adding a T-cell epitope from OVA to the priming and boosting immunogens. A prime with HEL followed by a boost with phage bearing a HEL-specific peptide, produced a moderate increase in Abs that cross-react with HEL. However, this came at the expense of producing a de novo Ab response to non-targeted epitopes on the boosting immunogen. Taken together, these results suggest that, in some situations, moderate epitope targeting is possible; however, more studies are required to optimize this approach.
Document
Copyright statement
Copyright is held by the author.
Permissions
The author has not granted permission for the file to be printed nor for the text to be copied and pasted. If you would like a printable copy of this thesis, please contact summit-permissions@sfu.ca.
Scholarly level
Language
English
Download file Size
etd3215.pdf 16.2 MB

Views & downloads - as of June 2023

Views: 0
Downloads: 1